Sativex Thorough QT/QTc Study

Clinical trial NCT01322139 · COMPLETED

Trial details

NCT number: NCT01322139
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Effects of Sativex on ECG

Start date: 2007-12-01
Primary completion: 2008-06-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.